Modular Medical, Inc. (MODD) stock
MODDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends March 31
$1.80−0.11 (-5.76%)
Close on Nov 17, 2026Market cap $14.67MP/E –Yield –
Modular Medical r&d expenses
Research and development expenses are spending on new products and technology.
Modular Medical's R&D Expenses for the twelve months ending Jun 30, 2026 was $19.21M, up 15.5% year over year. For fiscal 2026 it was $19.97M, up 35.9% from the year before. The highest annual figure on record is $19.97M in fiscal 2026.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | $19.97M | +35.9% |
| FY2025 | Mar 31, 2025 | $14.70M | +14.1% |
| FY2024 | Mar 31, 2024 | $12.88M | +42.1% |
| FY2023 | Mar 31, 2023 | $9.06M | +17.2% |
| FY2022 | Mar 31, 2022 | $7.73M | +89.3% |
| FY2021 | Mar 31, 2021 | $4.08M | +34.6% |
| FY2020 | Mar 31, 2020 | $3.03M | +61.2% |
| FY2019 | Mar 31, 2019 | $1.88M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | $4.37M | -14.9% |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | $3.84M | -2.4% |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | $5.41M | +40.3% |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | $5.59M | +51.1% |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | $5.13M | +60.2% |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | $3.94M | +26.4% |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | $3.85M | +0.4% |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | $3.70M | +17.2% |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | $3.21M | +15.8% |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | $3.12M | +38.0% |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | $3.84M | +74.7% |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $3.16M | +32.5% |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | $2.77M | +24.6% |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | $2.26M | +13.7% |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | $2.20M | +18.8% |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | $2.39M | +13.3% |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | $2.22M | +24.3% |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | $1.99M | +112.9% |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | $1.85M | +70.2% |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | $2.11M | +92.7% |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | $1.79M | +84.2% |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | $933.15K | -14.3% |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | $1.09M | +78.7% |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | $1.09M | +72.6% |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | $970.82K | +37.9% |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | $1.09M | +24.6% |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | $608.02K | +20.5% |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | $633.24K | +72.3% |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | $703.78K | +418.3% |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | $874.22K | – |
| Q3 FY2019CQ4 2018 | Dec 31, 2018 | $504.79K | – |
| Q2 FY2019CQ3 2018 | Sep 30, 2018 | $367.55K | – |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | $135.79K | – |
See a number that looks wrong?